Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Medical Genetics · CLCN4-Related Neurodevelopmental Disorder

Understanding Your Diagnosis: CLCN4-Related Disorder

At a Glance

CLCN4-related disorder is a rare genetic condition that can cause intellectual disability, speech and language delay, seizures, behavioral differences, and movement or head-growth changes. Symptoms vary widely, and X-inactivation testing in blood cannot reliably predict severity in females.

Receiving a diagnosis of CLCN4-related neurodevelopmental disorder can feel overwhelming, especially because this condition is exceptionally rare. It is completely normal to feel uncertain or fatigued by the diagnostic journey. You may find that many doctors, including specialists, have never treated a patient with this specific genetic change before [1]. Because so few cases have been documented worldwide—one of the largest single studies followed a cohort of only 52 individuals—the exact number of people living with this condition is unknown [1][2]. This rarity means that while the medical community is still learning, your child’s care will need to be highly personalized rather than following a “one-size-fits-all” guidebook.

What is CLCN4-Related Disorder?

A CLCN4-related neurodevelopmental disorder is a condition caused by a change (variant) in the CLCN4 gene, which provides instructions for making an endosomal chloride/proton (2Cl−/H+) exchanger in the body [1]. This exchanger helps regulate the movement of chloride and hydrogen ions inside cells, which is essential for the healthy functioning of the brain [3]. When the gene is altered, it can disrupt how brain cells communicate, leading to a range of developmental and neurological challenges [4].

The Spectrum of Symptoms

One of the most important things to understand about CLCN4-related disorder is its variability. This means that two children with the same genetic diagnosis can have very different experiences [4].

  • Intellectual Disability (ID): This is a core feature of the disorder, but the severity ranges widely from borderline or mild to profound [1][2].
  • Speech and Language: Most individuals experience significant delays in speech and language development [4].
  • Epilepsy: Approximately half of individuals (about 54% in some reviews) develop seizures [4]. These often begin in the first year of life and can be difficult to manage with standard medications (drug-resistant epilepsy) [2].
  • Behavioral Features: Many families report behavioral challenges, including autistic features, mood disorders, or obsessive-compulsive behaviors [1][5].
  • Physical Findings: Some children may have microcephaly (a smaller-than-average head size), differences in muscle tone, or movement disorders [1][2].

Understanding X-Linked Inheritance

The CLCN4 gene is located on the X chromosome. Humans typically have two sex chromosomes: females usually have two X chromosomes (XX), and males usually have one X and one Y (XY).

Because males (hemizygous) have only one X chromosome, a variant in the CLCN4 gene will often affect them significantly, though severity still varies. However, it is a major misconception that “X-linked” means only males are severely affected. Heterozygous females can range from apparently unaffected to as severely affected as males [1][5].

The Mystery of X-Inactivation

In females, one of the two X chromosomes in every cell is naturally “turned off” or inactivated. This process, called X-inactivation, is usually random. Doctors sometimes perform a blood test to see if a female has “skewed” X-inactivation, meaning one X chromosome is turned off more often than the other.

It was once thought that this blood test could predict how severe a girl’s symptoms would be. However, research has shown that X-inactivation levels in the blood do NOT reliably predict the severity of symptoms in CLCN4-related disorder [1]. A girl might have “normal” results in her blood test but still face profound challenges because the X-inactivation in her brain cells may be different than what is seen in her blood [1].

Why the Diagnosis is Rare

Because this condition was only recently identified as a distinct disorder, it is likely “under-diagnosed.” Many older children or adults with similar symptoms may have never received the specific genetic testing needed to identify a CLCN4 variant [5].

While the “at least 52 to 60” cases cited in major studies may seem like a tiny number, the community of families is growing as genetic testing becomes more common [1][6]. Your child’s variant may be de novo (a new change that happened for the first time in them) or it may have been inherited from a parent who may or may not show symptoms themselves [1][4]. Knowing whether the variant is inherited is vital for understanding the risks for other family members, and a genetic counselor can help guide predictive testing for relatives.

Common questions in this guide

What is CLCN4-related disorder?
CLCN4-related disorder is a rare genetic condition caused by a change in the CLCN4 gene. It affects brain development and can lead to differences in learning, speech, seizures, behavior, movement, or head growth. The combination and severity of features vary substantially from person to person.
What symptoms might a child with CLCN4-related disorder have?
Common features include intellectual disability and delayed speech or language development. Some children have epilepsy, autistic features, mood or obsessive-compulsive behaviors, a small head size, differences in muscle tone, or movement disorders. Severity can range from mild to profound.
Can girls and women be seriously affected by CLCN4-related disorder?
Yes. Females with one altered copy of CLCN4 can have no obvious symptoms, mild challenges, or effects as severe as those seen in males. The label X-linked does not mean that only males are significantly affected.
Does an X-inactivation blood test predict how severe CLCN4-related disorder will be?
Not reliably. X-inactivation measured in blood may differ from X-inactivation in the brain, where it may have a different effect on symptoms. A blood result should not be used alone to predict a girl's or woman's developmental or neurological outlook.
Is a CLCN4 variant inherited or does it happen for the first time?
Either is possible: the variant may be de novo, meaning it is new in the child, or inherited from a parent. If a mother carries one altered CLCN4 copy, each pregnancy has a 50% chance of inheriting the variant, although the effects can vary widely. A genetic counselor can discuss testing for relatives and the small possibility that a parent has the variant in some reproductive cells even if routine testing does not show it.
How common is CLCN4-related disorder?
It is exceptionally rare, and the exact number of people affected is unknown. Published studies have included only small groups, and the condition may be underdiagnosed because genetic testing was not always available or performed. More cases are being identified as testing becomes more common.
How likely is epilepsy in CLCN4-related disorder, and when can seizures begin?
About half of affected individuals develop epilepsy, and seizures often begin during the first year of life. Some seizures can be difficult to control with standard medicines. Families should discuss any unusual movements, staring episodes, or other suspected seizures promptly with the child’s healthcare team.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on CLCN4-related X-linked intellectual disability syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific variant identified in my child's CLCN4 gene, and is it a 'de novo' (new) or inherited variant?
  2. 2.Given the broad range of severity in CLCN4-related disorder, where does my child currently fall on the developmental and cognitive spectrum?
  3. 3.If my child is female, how should we interpret her symptoms given that blood-based X-inactivation testing is not a reliable predictor of severity?
  4. 4.What is the risk of my child developing epilepsy, and what specific seizure types (like myoclonic seizures) should I be watching for?
  5. 5.Are there any specific behavioral or psychiatric signs, such as autistic features or obsessive-compulsive behaviors, that we should screen for early?
  6. 6.Can we meet with a genetic counselor to discuss recurrence risks, such as the 50% chance for a heterozygous mother or germline mosaicism risks?

References

References (6)
  1. 1

    De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.

    Palmer EE, Stuhlmann T, Weinert S, et al.

    Molecular psychiatry 2018; (23(2)):222-230 doi:10.1038/mp.2016.135.

    PMID: 27550844
  2. 2

    Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients.

    He H, Li X, Guzman GA, et al.

    Journal of neurology 2024; (271(8)):4933-4948 doi:10.1007/s00415-024-12383-4.

    PMID: 38758281
  3. 3

    Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition.

    Palmer EE, Pusch M, Picollo A, et al.

    Molecular psychiatry 2023; (28(2)):668-697 doi:10.1038/s41380-022-01852-9.

    PMID: 36385166
  4. 4

    The molecular and phenotypic spectrum of CLCN4-related epilepsy.

    He H, Guzman RE, Cao D, et al.

    Epilepsia 2021; (62(6)):1401-1415 doi:10.1111/epi.16906.

    PMID: 33951195
  5. 5

    Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability.

    Li S, Zhang W, Liang P, et al.

    Frontiers in neurology 2023; (14()):1096969 doi:10.3389/fneur.2023.1096969.

    PMID: 37789889
  6. 6

    Clinical features and genetic analysis of epilepsy caused by CLCN4 gene mutation: a case report and literature review.

    Mao DD, Li SX, Hu WG, Chen H

    Translational pediatrics 2025; (14(7)):1717-1725 doi:10.21037/tp-2025-157.

    PMID: 40800199

This page is for informational purposes only and does not constitute medical advice. Your child’s neurologist, geneticist, and genetic counselor can interpret the genetic result and guide care for your family.